Human HLA-Ev (147) Expression in Transgenic Animals

R. Matsuura, A. Maeda, R. Sakai, H. Eguchi, P. C. Lo, H. Hasuwa, M. Ikawa, K. Nakahata, M. Zenitani, T. Yamamichi, S. Umeda, K. Deguchi, H. Okuyama, S. Miyagawa

研究成果: Article査読

2 被引用数 (Scopus)


Background In our previous study, we reported on the development of substituting S147C for HLA-E as a useful gene tool for xenotransplantation. In this study we exchanged the codon of HLA-Ev (147), checked its function, and established a line of transgenic mice. Methods A new construct, a codon exchanging human HLA-Ev (147) + IRES + human beta 2-microgloblin, was established. The construct was subcloned into pCXN2 (the chick beta-actin promoter and cytomegalovirus enhancer) vector. Natural killer cell- and macrophage-mediated cytotoxicities were performed using the established the pig endothelial cell (PEC) line with the new gene. Transgenic mice with it were next produced using a micro-injection method. Results The expression of the molecule on PECs was confirmed by the transfection of the plasmid. The established molecules on PECs functioned well in regulating natural killer cell-mediated cytotoxicity and macrophage-mediated cytotoxicity. We have also successfully generated several lines of transgenic mice with this plasmid. The expression of HLA-Ev (147) in each mouse organ was confirmed by assessing the mRNA. The chick beta-actin promoter and cytomegalovirus enhancer resulted in a relatively broad expression of the gene in each organ, and a strong expression in the cases of the heart and lung. Conclusion A synthetic HLA-Ev (147) gene with a codon usage optimized to a mammalian system represents a critical factor in the development of transgenic animals for xenotransplantation.

ジャーナルTransplantation Proceedings
出版ステータスPublished - 2016 5 1

ASJC Scopus subject areas

  • Surgery
  • Transplantation

フィンガープリント 「Human HLA-Ev (147) Expression in Transgenic Animals」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。